U.S. News & World Report Best Hospitals Rankings

Children’s Hospital Los Angeles is the First in California to Use the EvoEndo® System for Unsedated Pediatric Endoscopy

Retrieved on:

화요일, 4월 18, 2023

CHLA is the largest provider of care for children in Los Angeles County and, according to U.S. News & World Report’s 2022-23 Best Children’s Hospitals list, the top-ranked children’s hospital in California and the Pacific U.S. region.

Key Points:

CHLA is the largest provider of care for children in Los Angeles County and, according to U.S. News & World Report’s 2022-23 Best Children’s Hospitals list, the top-ranked children’s hospital in California and the Pacific U.S. region.
EvoEndo pairs its scope with virtual reality technology designed for patient distraction, further enabling an unsedated option.
The Training Head Model replicates the anatomy of the nose and pharynx, enabling the practice of TNE using the EvoEndo System in a non-clinical setting.
The EvoEndo® Controller is intended for use with an EvoEndo® Endoscope for endoscopic diagnosis, treatment, and video observation.

Intera Oncology Showcases Intera 3000 Hepatic Artery Infusion (HAI) Pump at the Annual Cholangiocarcinoma Foundation Conference

Retrieved on:

수요일, 4월 12, 2023

Intera Oncology® Inc. , manufacturer of the only FDA-approved pump for Hepatic Artery Infusion (HAI) therapy for the treatment of intrahepatic cholangiocarcinoma (bile duct cancer confined to the liver) and colorectal cancer liver metastases, will showcase its Intera 3000 HAI pump as a sponsor of the 10th annual Cholangiocarcinoma Foundation Conference April 12 to 15 in Salt Lake City, Utah.

Key Points:

Intera Oncology® Inc. , manufacturer of the only FDA-approved pump for Hepatic Artery Infusion (HAI) therapy for the treatment of intrahepatic cholangiocarcinoma (bile duct cancer confined to the liver) and colorectal cancer liver metastases, will showcase its Intera 3000 HAI pump as a sponsor of the 10th annual Cholangiocarcinoma Foundation Conference April 12 to 15 in Salt Lake City, Utah.
View the full release here: https://www.businesswire.com/news/home/20230412005035/en/
Intera Oncology showcases its Intera 3000 HAI pump at the Cholangiocarcinoma Foundation Conference to help educate patients about Hepatic Artery Infusion therapy, a powerful treatment option for bile duct cancer within the liver.
(Photo: Business Wire)
Intrahepatic cholangiocarcinoma (IHCC) has a very poor prognosis and patients treated with standard chemotherapy rarely survive beyond three years.
“Intera Oncology is passionate about ensuring anyone who can benefit from HAI therapy has access to it.

TGH Imaging Powered by Tower is the First in Florida to Install GE HealthCare's Omni Legend Digital PET/CT System

Retrieved on:

월요일, 3월 27, 2023

TAMPA, Fla., March 27, 2023 /PRNewswire/ -- As part of its commitment to providing advanced imaging diagnoses for complex medical care, TGH Imaging powered by Tower is the first in Florida to install the new Omni Legend digital PET/CT system from GE HealthCare. Now available in Tampa, Fla., at 4719 N. Habana Ave., the Omni Legend is an innovative solution that harnesses the power of an advanced digital detector capable of producing high-resolution images and faster exam times[1]. This impressive, all-digital technology can help increase patient access and efficiency, creating a higher level of service to patients and physicians in the area.

Key Points:

This cutting edge all-digital PET-CT system installation will enhance TGH Imaging's oncology, cardiac and neurological applications expanding its diagnostic imaging network.
TAMPA, Fla., March 27, 2023 /PRNewswire/ -- As part of its commitment to providing advanced imaging diagnoses for complex medical care, TGH Imaging powered by Tower is the first in Florida to install the new Omni Legend digital PET/CT system from GE HealthCare.
This impressive, all-digital technology can help increase patient access and efficiency, creating a higher level of service to patients and physicians in the area.
In addition, USF medical, nursing, pharmacy and physical therapy students receive part of their training at Tampa General.

Physical Rehabilitation Network & MemorialCare Open New Outpatient Physical Therapy Clinic in Huntington Beach

Retrieved on:

화요일, 3월 21, 2023

Carlsbad, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Physical Rehabilitation Network (PRN) , a leading US-based, owner-operator of over 200 physical therapy clinics, today announced the grand opening of its second outpatient physical therapy clinic in Huntington Beach.

Key Points:

Carlsbad, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Physical Rehabilitation Network (PRN) , a leading US-based, owner-operator of over 200 physical therapy clinics, today announced the grand opening of its second outpatient physical therapy clinic in Huntington Beach.
“We are incredibly excited to expand our leading physical care programs in the Huntington Beach community,” said Ajay Gupta, CEO, PRN.
“With a collaborative joint-venture partner like MemorialCare, we continue to broaden access to our tailor-made approach to physical therapy across the communities we support.
“PRN’s network of physical therapy clinics is one of the fastest expanding in the country, with a reach that enables us to provide patients a comprehensive range of treatments.”
The new Huntington Beach clinic, located at 18682 Beach Boulevard Ste.

Intera Oncology Relaunches Hepatic Artery Infusion (HAI) Pump, Restoring Powerful Treatment Option for Patients Fighting Metastatic Cancer in the Liver

Retrieved on:

목요일, 3월 16, 2023

Intera Oncology® Inc. has reintroduced Hepatic Artery Infusion (HAI) therapy to the market after its discontinuation in 2018 by the prior manufacturer dismayed patients and physicians.

Key Points:

Intera Oncology® Inc. has reintroduced Hepatic Artery Infusion (HAI) therapy to the market after its discontinuation in 2018 by the prior manufacturer dismayed patients and physicians.
The pump is designed to deliver a continuous flow of chemotherapy directly to the hepatic artery that feeds metastatic tumors in the liver.
Six years later, she is an advocate that encourages other colorectal cancer patients to consider the HAI pump to treat liver metastases.
It’s truly amazing that Intera Oncology as a company was created for the sole purpose of bringing back a treatment that is so desperately needed.

MONEY ANNOUNCES FIRST-EVER BEST HOSPITALS FOR BARIATRIC SURGERY LIST

Retrieved on:

월요일, 1월 30, 2023

DORADO, Puerto Rico, Jan. 30, 2023 /PRNewswire/ -- Money.com, in partnership with The Leapfrog Group, announced today its first-ever Best Hospitals for Bariatric Surgery list .

Key Points:

DORADO, Puerto Rico, Jan. 30, 2023 /PRNewswire/ -- Money.com, in partnership with The Leapfrog Group, announced today its first-ever Best Hospitals for Bariatric Surgery list .
Hospitals on this prestigious list meet Leapfrog standards for the number of bariatric procedures performed at the hospital and by individual surgeons.
Visit the Best Hospitals for Bariatric Surgery here and an in-depth look at bariatric surgery in 2023 here .
The Best Hospitals for Bariatric Surgery follows Money's previous "Best Of" lists, including the Best Hospitals in America , the Best Hospitals for Maternity Care and the Best Hospitals for Ethical Billing .

Carrum Health and UChicago Medicine Collaborate to Increase Access to High-Quality, Cost-Effective Cancer Care for Employers in the Midwest

Retrieved on:

수요일, 1월 25, 2023

SAN FRANCISCO, Jan. 25, 2023 /PRNewswire/ -- Carrum Health, the first digital health company connecting employers and employees to Centers of Excellence (COEs) through a technology-powered value-based care platform, today announces an arrangement with the University of Chicago Medicine to bring value-based breast cancer treatment and care to self-insured employers and their employees in the Midwest. Eligible patients can now receive treatment for non-metastatic breast cancer at UChicago Medicine, including surgery, reconstruction, chemotherapy, and radiation, for up to two years through Carrum Health's fixed-price comprehensive cancer care bundle.

Key Points:

UChicago Medicine, one of the nation's leading academic health systems, offers a regional network of care throughout the Chicagoland area.
14 in the country for cancer care in the latest edition of U.S. News & World Report's Best Hospitals list.
Carrum is thrilled to partner with such a high-quality provider like UChicago Medicine to extend our cancer care bundle to employers in the Midwest."
Increasing Access to High-Quality Cancer Care: Carrum Health partners with the top cancer centers across the U.S., such as UChicago Medicine, to ensure employers have access to local treatment and care for their employees.

HEALTHGRADES NAMES 2023 AMERICA'S BEST HOSPITALS

Retrieved on:

화요일, 1월 17, 2023

DENVER, Jan. 17, 2023 /PRNewswire/ -- Healthgrades, the #1 site Americans use to find a doctor or hospital, today announced the recipients of the 2023 America's Best Hospitals Awards and State Rankings. This year's achievements recognize the national leaders in overall clinical excellence and the top-ranked hospitals for specialty care by state.

Key Points:

Healthgrades announces the highest performing hospitals in the U.S. for clinical excellence and names the top-ranked hospitals by state
DENVER, Jan. 17, 2023 /PRNewswire/ -- Healthgrades , the #1 site Americans use to find a doctor or hospital, today announced the recipients of the 2023 America's Best Hospitals Awards and State Rankings.
To determine the top 250 U.S. hospitals, Healthgrades evaluated clinical performance for nearly 4,500 hospitals across more than 31 of the most common procedures and conditions.
In tandem with the national recognition, Healthgrades measured the hospitals across 18 key specialty areas* to identify the highest-ranking hospitals in 32 eligible states.
In fact, if all hospitals performed similarly to America's 250 Best Hospitals, 160,615 lives could have been saved.

President Biden signs law designating TIRR Memorial Hermann as "National Rehabilitation Innovation Center"

Retrieved on:

수요일, 1월 11, 2023

HOUSTON , Jan. 11, 2023 /PRNewswire/ -- TIRR Memorial Hermann is honored to be designated as a national rehabilitation innovation center as a result of legislation passed by Congress and signed into law by President Joe Biden on Jan. 5, 2023.

Key Points:

HOUSTON , Jan. 11, 2023 /PRNewswire/ -- TIRR Memorial Hermann is honored to be designated as a national rehabilitation innovation center as a result of legislation passed by Congress and signed into law by President Joe Biden on Jan. 5, 2023.
The Dr. Joanne Smith Memorial Rehabilitation Innovation Centers Act of 2022 recognizes a leading class of pioneering rehabilitation research facilities across the country, including TIRR Memorial Hermann, which set the standard for ongoing study and patient care.
"From the earliest foundational days providing rehabilitation to individuals affected by polio, TIRR Memorial Hermann has been known for embracing innovation within our clinical, education, research and advocacy efforts.
Memorial Hermann Health System operates eight TIRR Memorial Hermann facilities across the Greater Houston area, in addition to facilities which are part of the Memorial Hermann Rehabilitation Network.

Corporate Reputation of Pharma in United States, 2021-2022: The Patient Perspective - The Views of 240 Patient Groups - ResearchAndMarkets.com

Retrieved on:

월요일, 1월 9, 2023

The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - USA Edition - The Views of 240 USA Patient Groups" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - USA Edition - The Views of 240 USA Patient Groups" report has been added to ResearchAndMarkets.com's offering.
Patient groups responding to the 'Corporate Reputation of Pharma' survey are uniquely positioned to comment on the pharma industry's performance during the pandemic.
The report provides highlights on:
The 240 US patient groups responding to the 2021 survey rated the pharma industry more favourably for corporate reputation than their predecessors in previous years.
2021's 240 respondent US patient groups registered significant drops in their approval ratings when asked in the 'Corporate Reputation' survey about specific pharma activities of importance to patients and patient groups - especially patient safety, patient centricity, patient information, and integrity.